STARTUP PROFILE

Phantom Neuro

COUNTRY
USA
FOUNDED
2016
CATEGORY
Tools and Infrastructure
Developing minimally invasive muscle implants and AI-driven interfaces enabling intuitive prosthetic and robotic limb control for amputees.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series A
MODALITY
EMG
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Rehabilitation
TARGET USER
Patients
REGULATORY STAGE
Investigational
Phantom Neuro takes a peripheral route to prosthetic and robotic control, using minimally invasive muscle implants and AI decoding rather than cortical interfaces. This gives it a pragmatic path to market, with lower procedural burden than brain implants and potentially stronger signal fidelity than surface EMG.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
12
NVIDIA and OpenAI invest in neurotech
13 October – 27 October 2026

Phantom Neuro implanted its Phantom X neural interface in the first participants of its CYBORG study at Cabrini Health in Melbourne. The device sits beneath the skin over the muscles of a residual limb, detecting signals when users try to move missing fingers or a wrist and converting them into wireless commands for a prosthetic arm. The study plans to enroll 10 people with below-the-elbow amputations. Phantom, which raised a $19M Series A led by Ottobock last year, also announced plans to raise a $30M Series B.

Articles featuring
Phantom Neuro